Volume 35, Issue 10 (12-2024)
Studies in Medical Sciences 2024, 35(10): 842-849 |
Back to browse issues page
Ethics code: R.IAU.YAZD.REC.1402.042
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Halvani A, Rafatmagham S, Nedaiefard R. INVESTIGATION OF FINDINGS OF THORAX CT SCAN IN PATIENTS WITH PLEURAL MALIGNANCY AT SHAHID SADOUGHI HOSPITAL AND OTHER MEDICAL CENTERS IN YAZD CITY. Studies in Medical Sciences 2024; 35 (10) :842-849
URL: http://umj.umsu.ac.ir/article-1-6366-en.html
URL: http://umj.umsu.ac.ir/article-1-6366-en.html
Department of Internal Medicine, Faculty of Medicine, Fasa University of Medical Sciences, Fasa, Iran (Corresponding Author) , r.sareh2012@gmail.com
Abstract: (416 Views)
Background & Aim: Accurate diagnosis of pleural neoplasms, especially in the early stages, is crucial for improving patient prognosis. Imaging tools such as CT scans play a significant role in identifying the type, location, and extent of pleural involvement. This study aimed to investigate CT scan findings in patients with pleural malignancies and analyze their association with demographic factors, smoking history, tumor type, and disease duration.
Materials & Methods: This cross-sectional descriptive-analytical study was conducted on patients with pleural malignancies. Data were analyzed using SPSS software and statistical tests, including Chi-square, Fisher's Exact test, and ANOVA.
Results: Among 100 patients (68 men and 32 women), the mean age was 54.32 ± 16.99 years, and the mean disease duration was 5.74 ± 3.48 months. Fifty-seven patients had a history of smoking. Fourteen patients had primary tumors, while 86 had metastatic tumors. CT scan findings included pleural involvement (100%), pleural effusion (100%), lung volume reduction (92%), pleural thickening (85%), pleural nodularity (57%), lymphadenopathy (56%), lung parenchymal infiltration (45%), mediastinal shift (28%), and pericardial thickening (24%).
Conclusion: CT scan findings in pleural malignancies, except for lung parenchymal infiltration, which was more common in men, showed no association with age, gender, tumor type, disease duration, or smoking history. The origin of metastatic tumors only influenced the occurrence of lymphadenopathy. This study demonstrates that CT scans are a valuable tool for diagnosing and evaluating pleural malignancies.
Materials & Methods: This cross-sectional descriptive-analytical study was conducted on patients with pleural malignancies. Data were analyzed using SPSS software and statistical tests, including Chi-square, Fisher's Exact test, and ANOVA.
Results: Among 100 patients (68 men and 32 women), the mean age was 54.32 ± 16.99 years, and the mean disease duration was 5.74 ± 3.48 months. Fifty-seven patients had a history of smoking. Fourteen patients had primary tumors, while 86 had metastatic tumors. CT scan findings included pleural involvement (100%), pleural effusion (100%), lung volume reduction (92%), pleural thickening (85%), pleural nodularity (57%), lymphadenopathy (56%), lung parenchymal infiltration (45%), mediastinal shift (28%), and pericardial thickening (24%).
Conclusion: CT scan findings in pleural malignancies, except for lung parenchymal infiltration, which was more common in men, showed no association with age, gender, tumor type, disease duration, or smoking history. The origin of metastatic tumors only influenced the occurrence of lymphadenopathy. This study demonstrates that CT scans are a valuable tool for diagnosing and evaluating pleural malignancies.
References
1. Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024; 74(1):12-49. doi: 10.3322/caac.21820. [DOI:10.3322/caac.21820] [PMID]
2. Ayob AZ and Ramasamy TS. Cancer stem cells as key drivers of tumour progression. J Biomed Sci. 2018; 25(1):20. Epub 2018/03/07. [DOI:10.1186/s12929-018-0426-4] [PMID] []
3. Cambria E, Coughlin MF, Floryan MA, Offeddu GS, Shelton SE, Kamm RD. Linking cell mechanical memory and cancer metastasis. Nat Rev Cancer. 2024;24(3):216-228. doi: 10.1038/s41568-023-00656-5. Epub 2024 Jan 18. PMID: 38238471; PMCID: PMC11146605. [DOI:10.1038/s41568-023-00656-5] [PMID] []
4. Suski JM, Braun M, Strmiska V, Sicinski P. Targeting cell-cycle machinery in cancer. Cancer Cell. 2021;14;39(6):759-78. doi: 10.1016/j.ccell.2021.03.010. [DOI:10.1016/j.ccell.2021.03.010] [PMID] []
5. Hopkins JL, Lan L, Zou L. DNA repair defects in cancer and therapeutic opportunities. Genes Dev. 2022;36(5-6):278-93. doi: 10.1101/gad.349431. [DOI:10.1101/gad.349431.122] [PMID] []
6. Kashyap D, Garg VK, Goel N. Intrinsic and extrinsic pathways of apoptosis: Role in cancer development and prognosis. Adv Protein Chem Struct Biol. 2021;125:73-120. doi: 10.1016/bs.apcsb.2021.01.003. [DOI:10.1016/bs.apcsb.2021.01.003] [PMID]
7. WHO. Global cancer burden growing, amidst mounting need for services [Internet]. [cited 2025 Feb 15]. Available from: https://www.who.int/news/item/01-02-2024-global-cancer-burden-growing--amidst-mounting-need-for-services
8. Sharma AN, Dewangan HK, Upadhyay PK. Comprehensive Review on Herbal Medicine: Emphasis on Current Therapy and Role of Phytoconstituents for Cancer Treatment. Chem Biodivers. 2024;21(3):e202301468. doi: 10.1002/cbdv.202301468. [DOI:10.1002/cbdv.202301468] [PMID]
9. Kassaye D, Amberbir A, Getachew B, Mussema Y. A historical overview of traditional medicine practices and policy in Ethiopia. Ethiop.J.Health Dev, 2006; 20(2): 127-34 [DOI:10.4314/ejhd.v20i2.10023]
10. Lovika B, Fauziah F, and Bellatasie R. Cytotoxic Activity of Piper cubeba: A Review, IRJPMS, 2021; 4(3): 12-8. [google scholar]
11. Zuhair T, Abdul J, Ahmed N. Piper cubeba: phytochemical and pharmacological review of a routinely used spices. 2022; 10.31838/ijpr/2020.SP1.119. [google scholar]
12. Drissi B, Mahdi I, Yassir M, Ben Bakrim W, Bouissane L and Sobeh M.Cubeb (Piper cubeba L.f.): A comprehensive review of its botany, phytochemistry, traditional uses, and pharmacological properties. Front. Nutr. 2022; 9:1048520. doi: 10.3389/fnut.2022.1048520 [DOI:10.3389/fnut.2022.1048520] [PMID] []
13. Booms A, Coetzee GA, Pierce SE. MCF-7 as a Model for Functional Analysis of Breast Cancer Risk Variants. Cancer Epidemiol Biomarkers Prev. 2019;28(10):1735-1745. doi: 10.1158/1055-9965.EPI-19-0066. [DOI:10.1158/1055-9965.EPI-19-0066] [PMID] []
14. Graidist P, Martla M, Sukpondma Y. Cytotoxic activity of Piper cubeba extract in breast cancer cell lines. Nutrients. 2015;10;7(4):2707-18. doi: 10.3390/nu7042707. [DOI:10.3390/nu7042707] [PMID] []
15. Ouyang L, Shi Z, Zhao S, Wang FT, Zhou TT, Liu B, Bao JK. Programmed cell death pathways in cancer: a review of apoptosis, autophagy and programmed necrosis. Cell Prolif. 2012;45(6):487-98. doi: 10.1111/j.1365-2184.2012.00845.x. [DOI:10.1111/j.1365-2184.2012.00845.x] [PMID] []
16. Saraste A and Pulkki K. Morphologic and biochemical hallmarks of apoptosis. Cardiovascular research, 2000; 45(3): 528-537. [DOI:10.1016/S0008-6363(99)00384-3] [PMID]
17. Johnson JJ and Mukhtar H. Curcumin for chemoprevention of colon cancer. Cancer letters, 2007; 255(2): 170-81. [DOI:10.1016/j.canlet.2007.03.005] [PMID]
18. Yam J, Kreuter M, Drewe J. Piper cubeba targets multiple aspects of the androgen-signalling pathway. A potential phytotherapy against prostate cancer growth? Planta Med. 2008;74(1):33-8. doi: 10.1055/s-2007-993758. Epub 2007; PMID: 18080233. [DOI:10.1055/s-2007-993758] [PMID]
19. Gusson-Zanetoni JP, da Silva JSGM, Picão TB, Cardin LT, Prates J, Sousa SO, Henrique T, Oliani SM, Tajara EH, E Silva MLA, Cunha NL, da Silva Gomes AC, Laurentiz RS, Rodrigues-Lisoni FC. Effect of Piper cubeba total extract and isolated lignans on head and neck cancer cell lines and normal fibroblasts. J Pharmacol Sci. 2022;148(1):93-102. doi: 10.1016/j.jphs.2021.09.002. Epub 2021; PMID: 34924135. [DOI:10.1016/j.jphs.2021.09.002] [PMID]
20. Niwa AM, de Paula NA, Vesenick DC, Sartori D, Maistro EL, Ribeiro LR, et al. Evaluation of lignan (-)-cubebin extracted from Piper cubeba on human colon adenocarcinoma cells (HT29). Null. 2016 79:92-100. doi: 10.1080/15287394. 2015.1110067 [DOI:10.1080/15287394.2015.1110067] [PMID]
21. Grinevicius VMAS, Andrade KS, Ourique F, Micke GA, Ferreira SRS, Pedrosa RC. Antitumor activity of conventional and supercritical extracts from Piper nigrum L. Cultivar bragantina through cell cycle arrest and apoptosis induction. J Super Fluids. 2017; 128:94-101. doi: 10.1016/j.supflu.2017.05.009 [DOI:10.1016/j.supflu.2017.05.009]
22. Tabatabaee MS, Ahmadi R, and Kassaee MS. The Cytotoxic Effects of Hydroalcoholic Extract of Aerial Parts of Scrophularia striata on MCF-7 Cell Line and Evaluation of BAX and KAI1 Genes Expression. Qom Univ Med Sci J 2018; 12(9): 38-46. [DOI:10.29252/qums.12.9.38]
23. Hajebi S, Chehrangi RA, Lariyazdi H. Study of cytotoxic effect of essential oil of Tymus vulgaris L. By MTT and Trypan blue assay on breasr cancer cell line MCF-7. j dev biol, 2017; 1-12. [google scholar]
24. Fawzy RM, Abdel-Aziz AA, Bassiouny K, Fayed AM. Phytocompounds-based therapeutic approach: Investigating curcumin and green tea extracts on MCF-7 breast cancer cell line. J Genet Eng Biotechnol. 2024; 22(1): 100339,.
https://doi.org/10.1016/j.jgeb.2023.100339 [DOI:10.1016/j.jgeb.2023.100339.] [PMID] []
25. Das AK, Borah M, Kalita JJ, Bora U. Cytotoxic potential of Curcuma caesia rhizome extract and derived gold nanoparticles in targeting breast cancer cell lines. Sci Rep. 2024; 26;14(1):17223. doi: 10.1038/s41598-024-66175-x. [DOI:10.1038/s41598-024-66175-x] [PMID] []
26. Shiekhzadeh F, Mousavi SH, Amiri MS, Iranshahi M, Tayarani-Najaran Z, Karimi G. Cytotoxic and Apoptotic Potential of Rheum turkestanicum Janisch Root Extract on Human Cancer and Normal Cells. Iran J Pharm Res. 2013;12(4):811-9. PMID: 24523761; PMCID: PMC3920695. [PMID: 24523761] [PMCID: PMC3920695]
27. Mohammadi A, Mansoori B, ghakaboodi K C, Baradaran B. Cytotoxic effects of anacyclus pyrethrum plant extract in oral cancer cell(KB cell line). UNSU, 2016;27(4):257-65. (Persian) [google scholar]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
